Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002)

Johnny Chun Chau Sung; Ying Liu; Kam Chau Wu; Man Chung Choi; Chloe Ho Yi Ma; Jayman Lin; Emily Isabel Cheng He; David Yiu Ming Leung; Eric Tung Po Sze; Yusuf Khwaja Hamied; Dominic Man Kit Lam; Keith Wai Yeung Kwong

doi:10.3390/vaccines10111852

Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002)

Johnny Chun Chau Sung, Ying Liu, Kam Chau Wu, Man Chung Choi, Chloe Ho Yi Ma, Jayman Lin, Emily Isabel Cheng He, David Yiu Ming Leung, Eric Tung Po Sze, Yusuf Khwaja Hamied, Dominic Man Kit Lam, Keith Wai Yeung Kwong

Construction and Quality Management

Research output: Contribution to journal › Comment/debate

2 Citations (Scopus)

Abstract

The journal retracts the article “Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate” [1]. Following publication, concerns were brought to the attention of the publisher regarding the ethical approval not granted from Hong Kong Metropolitan University (HKMU). In adherence to our complaints procedure, an investigation was conducted, and the article is therefore retracted. This retraction was approved by the Publication Ethics Committee and the Editor-in-Chief. The authors agreed to this retraction.

Original language	English
Article number	1852
Journal	Vaccines
Volume	10
Issue number	11
DOIs	https://doi.org/10.3390/vaccines10111852
Publication status	Published - Nov 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/vaccines10111852

Fingerprint

Dive into the research topics of 'Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002)'. Together they form a unique fingerprint.

Cite this

Sung, J. C. C., Liu, Y., Wu, K. C., Choi, M. C., Ma, C. H. Y., Lin, J., He, E. I. C., Leung, D. Y. M., Sze, E. T. P., Hamied, Y. K., Lam, D. M. K., & Kwong, K. W. Y. (2022). Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002). Vaccines, 10(11), Article 1852. https://doi.org/10.3390/vaccines10111852

@article{d285812d9e8a4da097c251a7d8a14b8e,

title = "Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002)",

abstract = "The journal retracts the article “Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate” [1]. Following publication, concerns were brought to the attention of the publisher regarding the ethical approval not granted from Hong Kong Metropolitan University (HKMU). In adherence to our complaints procedure, an investigation was conducted, and the article is therefore retracted. This retraction was approved by the Publication Ethics Committee and the Editor-in-Chief. The authors agreed to this retraction.",

author = "Sung, {Johnny Chun Chau} and Ying Liu and Wu, {Kam Chau} and Choi, {Man Chung} and Ma, {Chloe Ho Yi} and Jayman Lin and He, {Emily Isabel Cheng} and Leung, {David Yiu Ming} and Sze, {Eric Tung Po} and Hamied, {Yusuf Khwaja} and Lam, {Dominic Man Kit} and Kwong, {Keith Wai Yeung}",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = nov,

doi = "10.3390/vaccines10111852",

language = "English",

volume = "10",

number = "11",

}

Sung, JCC, Liu, Y, Wu, KC, Choi, MC, Ma, CHY, Lin, J, He, EIC, Leung, DYM, Sze, ETP, Hamied, YK, Lam, DMK & Kwong, KWY 2022, 'Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002)', Vaccines, vol. 10, no. 11, 1852. https://doi.org/10.3390/vaccines10111852

Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002). / Sung, Johnny Chun Chau; Liu, Ying; Wu, Kam Chau et al.
In: Vaccines, Vol. 10, No. 11, 1852, 11.2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Retraction

T2 - Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002)

AU - Sung, Johnny Chun Chau

AU - Liu, Ying

AU - Wu, Kam Chau

AU - Choi, Man Chung

AU - Ma, Chloe Ho Yi

AU - Lin, Jayman

AU - He, Emily Isabel Cheng

AU - Leung, David Yiu Ming

AU - Sze, Eric Tung Po

AU - Hamied, Yusuf Khwaja

AU - Lam, Dominic Man Kit

AU - Kwong, Keith Wai Yeung

PY - 2022/11

Y1 - 2022/11

N2 - The journal retracts the article “Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate” [1]. Following publication, concerns were brought to the attention of the publisher regarding the ethical approval not granted from Hong Kong Metropolitan University (HKMU). In adherence to our complaints procedure, an investigation was conducted, and the article is therefore retracted. This retraction was approved by the Publication Ethics Committee and the Editor-in-Chief. The authors agreed to this retraction.

AB - The journal retracts the article “Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate” [1]. Following publication, concerns were brought to the attention of the publisher regarding the ethical approval not granted from Hong Kong Metropolitan University (HKMU). In adherence to our complaints procedure, an investigation was conducted, and the article is therefore retracted. This retraction was approved by the Publication Ethics Committee and the Editor-in-Chief. The authors agreed to this retraction.

UR - http://www.scopus.com/inward/record.url?scp=85143775215&partnerID=8YFLogxK

U2 - 10.3390/vaccines10111852

DO - 10.3390/vaccines10111852

M3 - Comment/debate

AN - SCOPUS:85143775215

VL - 10

JO - Vaccines

JF - Vaccines

IS - 11

M1 - 1852

ER -

Retraction: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate (Vaccines, (2022), 10, (2), 10.3390/vaccines10010002)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this